The large amount of plasma required by conventional methods for drug quantification makes mass spectrometry
combinedwith dried blood spot (DBS) sampling crucial for pediatric patientswhere therapeutic drug monitoring
or pharmacokinetic studiesmay be difficult to realize. DBS represents a new convenient sampling support requiring
minimally invasive blood drawing and providing long-term stability of samples and less expensive shipment
and storage.